Application of tirofiban in reperfusion treatment of acute ischemic stroke
10.3760/cma.j.issn.1673-4165.2019.12.007
- VernacularTitle: 替罗非班在急性缺血性卒中再灌注治疗中的应用
- Author:
Zhigang LIANG
1
;
Shuangfeng HUANG
1
,
2
;
Shaowan YANG
1
Author Information
1. Department of Neurology, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai 264000, China
2. School of Clinical Medicine, Binzhou Medical College, Yantai 264000, China
- Publication Type:Review
- Keywords:
Stroke;
Brain ischemia;
Tirofiban;
Thrombolytic therapy;
Fibrinolytic agents;
Thrombectomy;
Endovascular procedures
- From:
International Journal of Cerebrovascular Diseases
2019;27(12):914-919
- CountryChina
- Language:Chinese
-
Abstract:
Vascular recanalization is an important treatment method for acute ischemic stroke. Antiplatelet drugs combined with intravenous thrombolysis and endovascular therapy have become the research hotspots in recent years. Platelet glycoprotein Ⅱb/Ⅲa receptor antagonist is a new class of antiplatelet drugs that work by inhibiting the last common pathway in the platelet aggregation process. Its safety and effectiveness in the treatment of acute coronary syndrome have been proven, but its application in patients with acute ischemic stroke is still in the exploratory stage. This article reviews the application of tirofiban in the treatment of acute ischemic stroke reperfusion.
